MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 21.02.2026
XTL Biopharmaceuticals Ltd. Finanzkreislauf 2011-2026 | XTLB
Finanzkreislauf Jährlich XTL Biopharmaceuticals Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | -9.73 | -303 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -9.73 | -303 | -157 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B |  USA |
 |
Apellis Pharmaceuticals
APLS
|
115 | $ 20.29 | -1.98 % | $ 2.56 B | USA |
 |
Aptorum Group Limited
APM
|
-400 | $ 0.8 | -5.3 % | $ 4.36 M | China |
 |
Axsome Therapeutics
AXSM
|
-256 | $ 166.0 | -0.23 % | $ 8.26 B | USA |
 |
AbCellera Biologics
ABCL
|
173 | $ 3.74 | -2.23 % | $ 1.12 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Certara
CERT
|
81.8 | $ 7.22 | 2.34 % | $ 1.16 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
120 | $ 23.78 | -0.42 % | $ 2.91 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - |  Russia |
 |
Eton Pharmaceuticals
ETON
|
-6.66 | $ 17.9 | -1.38 % | $ 459 M | USA |
 |
Exelixis
EXEL
|
-8.32 | $ 40.5 | -1.29 % | $ 11 B | USA |
 |
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | Canada |
 |
Codexis
CDXS
|
-48.2 | $ 1.02 | -0.33 % | $ 74.9 M | USA |
 |
Galapagos NV
GLPG
|
67.1 | $ 33.13 | -2.82 % | $ 2.69 B |  Belgium |
 |
Halozyme Therapeutics
HALO
|
322 | $ 68.58 | -1.82 % | $ 8.22 B | USA |
 |
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | USA |
 |
Harmony Biosciences Holdings
HRMY
|
20.4 | $ 28.32 | -2.01 % | $ 1.63 B | USA |
 |
ImmuCell Corporation
ICCC
|
183 | $ 6.3 | -3.67 % | $ 51.5 M | USA |
 |
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
-6 K | $ 3.27 | -2.1 % | $ 1.17 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M |  Israel |
 |
Agios Pharmaceuticals
AGIO
|
735 | $ 28.57 | -2.16 % | $ 1.66 B | USA |
 |
Immuron Limited
IMRN
|
867 | $ 0.75 | -0.69 % | $ 6.46 M |  Australia |
 |
Inhibrx
INBX
|
31.1 | $ 76.39 | -1.42 % | $ 3.6 B | USA |
 |
InMed Pharmaceuticals
INM
|
184 | $ 0.8 | -2.44 % | $ 1.96 M | Canada |